RT Journal Article
SR Electronic
T1 Assessing feasibility and risk to translate, de-identify and summarize medical reports using deep learning
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.07.27.23293234
DO 10.1101/2023.07.27.23293234
A1 Gauthier, Lucas W.
A1 Willems, Marjolaine
A1 Chatron, Nicolas
A1 Cenni, Camille
A1 Meyer, Pierre
A1 Ruault, Valentin
A1 Wells, Constance
A1 Sabbagh, Quentin
A1 Genevieve, David
A1 Yauy, Kevin
YR 2023
UL http://medrxiv.org/content/early/2023/08/28/2023.07.27.23293234.abstract
AB Background Precision medicine requires accurate phenotyping and data sharing, particularly for rare diseases. However, sharing medical reports across language barriers is challenging. Alternatively, inconsistent and incomplete clinical summary provided by physicians using Human Phenotype Ontology (HPO) can lead to a loss of clinical information.Methods To assess feasibility and risk of using deep learning methods to translate, de-identify and summarize medical letters, we developed an open-source deep learning multi-language software in line with health data privacy. We conducted a non-inferiority clinical trial using deep learning methods to de-identify protected health information (PHI) targeting a minimum sensitivity of 90% and specificity of 75%, and summarize non-English medical letters in HPO format, aiming a sensitivity of 75% and specificity of 90%.Results From March to April 2023, we evaluated 50 non-English medical reports from 8 physicians and 12 different groups of diseases, which included neurodevelopmental disorders, congenital disorders, fetal pathology and oncology. Reports contain in median 15 PHI and 7 HPO terms. Deep learning method achieved a sensitivity of 99% and a specificity of 87% in de-identification, and a sensitivity of 78% and a specificity of 92% in summarizing medical reports, reporting an average number of 6.6 HPO terms per letter, which is equivalent to the number of HPO terms provided usually by physicians in databases (6.8 in PhenoDB).Conclusions De-identification and summarization of non-English medical letters using deep learning methods reports non-inferior performance, providing insights on AI usage to facilitate precision medicine.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://docs.google.com/document/d/1nNNZisBGYWE8XvJFNLgGmdsl3783oqBREE0V_uvGfK8/edit?usp=sharing Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board of University Hospital Center of Montpellier gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors https://huggingface.co/spaces/kyauy/ClinFly